3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
10
Prostatic Neoplasms
5
Lung Neoplasms
5
Endometrial Neoplasms
3
Breast Neoplasms
3
Stomach Neoplasms
2
Rectal Neoplasms
2
Pancreatic Neoplasms
2
Oropharyngeal Neoplasms
2
Neoplasms
2
Urinary Bladder Neoplasms
1
Ureteral Neoplasms
1
Triple Negative Breast Neoplasms
1
Thyroid Neoplasms
1
Thyroid Diseases
1
Stage I Mixed Cell Type Kidney Wilms Tumor
1
Squamous Cell Carcinoma of Head and Neck
1
Smoldering Multiple Myeloma
1
Small Cell Lung Carcinoma
1
Salivary Gland Neoplasms
1
Pneumonia
1
Pleuropulmonary blastoma
1
Pathologic Complete Response
1
Paranasal Sinus Neoplasms
1
Pancreatitis, Chronic
1
Neurocognitive Disorders
1
Neuroblastoma
1
Neoplasm Metastasis
1
Nasopharyngeal Neoplasms
1
Meningioma
1
Interventions
relugolix
2
acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide
2
Specimen Handling
2
Radiotherapy
2
Radiation
2
Magnetic Resonance Spectroscopy
2
Leuprolide
2
Goserelin
2
Biopsy
2
radium Ra 223 dichloride
1
luprolide acetate gel depot
1
histrelin
1
gallium 68 PSMA-11
1
enzalutamide
1
darolutamide
1
bicalutamide
1
Triptorelin Pamoate
1
Surgical Procedures, Operative
1
Salicylic Acid
1
Radiotherapy, Image-Guided
1
Radiosurgery
1
Radiation Dose Hypofractionation
1
Flutamide
1
Buserelin
1
2-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Prostate Adenocarcinoma
×
Observation
×
90 days
×
Clear all
No trials found.